glutathione metabolism and parkinson& 39 The Role of in Chronic Illness Development Its Potential Use as a Novel Therapeutic Target Revamping Parkinson's disease therapy using
Description
We can infer that PQ (or another drug) poses an oxidative challenge that G6PD normal red cells can withstand, but G6PD-deficient red cells cannot (see Figs 2 and 4)
BissaccoJBovenziRContiMSimonettaCMascioliDCerroniRet al
Nature 407(6806): 908-913
Many of these agents are not approved by the FDA for musculoskeletal indications and may be compounded or sourced outside regulated pharmaceutical manufacturing pathways
(2016) GTPase cross talk regulates TRAPPII activation of Rab11 homologues during vesicle biogenesis
Int J Androl 20:6169
